---
title: "Stem Cell Therapy for Type 2 Diabetes: What the Research Shows and Who May Be a Candidate"
description: "An honest guide to mesenchymal stem cell (MSC) therapy for type 2 diabetes: what the randomized trials show, how long effects lasted, our 300 million cell IV protocol and price, risks, and who may be a candidate."
canonical: "https://dreambody.clinic/stem-cell-therapy-type-2-diabetes-research/"
---

# Stem Cell Therapy for Type 2 Diabetes: What the Research Shows and Who May Be a Candidate

If you’ve lived with type 2 diabetes for a while, you probably know the pattern. You did what you were asked: changed how you eat, started metformin, maybe added a second or third medicine. For a while your numbers looked better. Then your A1C crept back up, a new prescription appeared, and at some point insulin entered the conversation.

That’s often when people start reading about stem cells. This guide explains what’s happening in type 2 diabetes, what standard care can do, what the published research on mesenchymal stem cells (MSCs) actually shows, exactly what our protocol involves and costs, and who may be a reasonable candidate. We’ll be straightforward with you: MSC therapy for type 2 diabetes is investigational. The randomized trials are small, the improvements they found were modest and faded over time, and nothing here replaces the care you get from your own doctor.

## What Happens in Type 2 Diabetes

Type 2 diabetes develops from two problems that build on each other:

- **Insulin resistance:** muscle, fat and liver cells stop responding well to insulin, so sugar stays in the blood.
- **Beta cell strain:** the insulin-making beta cells in the pancreas work harder to keep up, and over years many of them lose function.

Long-term, low-grade inflammation is part of the picture. Immune cells in fat tissue and elsewhere stay in an inflamed state that makes insulin resistance worse. Over time, high blood sugar can damage the nerves, kidneys, eyes, heart and blood vessels. Doctors track the disease with A1C (your average blood sugar over about three months), fasting glucose and, sometimes, C-peptide, a measure of how much insulin your own pancreas still makes.

## What Standard Care Can and Can't Do

Standard care is more powerful than it was even ten years ago. Weight loss, movement and nutrition changes can bring some people into remission. Metformin remains a strong first step. Newer medicines, including GLP-1 drugs and SGLT2 inhibitors, can lower A1C meaningfully, and some have been shown in large trials to protect the heart and kidneys. Insulin works for nearly everyone when it’s needed.

The honest gap: for many people, the disease keeps progressing anyway, medicines get added, and beta cell function continues to decline. That’s a real frustration and a fair reason to ask about other options. It isn’t, by itself, evidence that stem cells close the gap.

## How MSCs Are Thought to Work

MSCs act mainly as signalers in the body. They release proteins and tiny particles that can calm overactive inflammation and influence how nearby cells behave. Researchers call this paracrine signaling.

In type 2 diabetes, the idea being tested is that MSCs might temporarily dial down the inflammation that drives insulin resistance, and perhaps ease some of the stress on the beta cells that remain. What MSCs don’t appear to do is turn into new insulin-making cells. They rarely become pancreatic tissue in the body, and they’re cleared over time. So the realistic hope is a change in how well your body uses insulin, not a new pancreas. (For more on cell types, see our [plain-language guide to stem cells](https://dreambody.clinic/what-are-stem-cells-plain-language-guide/).)

## What Does the Research Show?

The human evidence for type 2 diabetes is stronger than for many conditions people ask us about, but it’s still limited. Here’s a fair summary.

- **A 36-month randomized trial (2016).** In a study from Qingdao University published in *Experimental and Therapeutic Medicine*, 61 people with type 2 diabetes received either two IV infusions of donor Wharton’s jelly MSCs four weeks apart (31 people) or saline (30 people), on top of their usual treatment. The cell group had significantly better A1C, after-meal glucose, C-peptide and beta cell function scores than the saline group, and fewer new diabetes complications over three years. No serious side effects were reported. Importantly, the authors found that blood sugar control held for about 21 months, then began to slip back.
- **A double-blind, placebo-controlled trial (2022).** In a study published in *Stem Cell Research & Therapy*, 91 adults with insulin-treated type 2 diabetes received three IV infusions of umbilical cord MSCs or a placebo, four weeks apart, and were followed for 48 weeks. A1C dropped by 1.31 points in the cell group versus 0.63 in the placebo group, and insulin doses fell more in the cell group. But only 20% of treated patients reached the main goal (A1C under 7% with at least a 50% cut in insulin), compared with about 5% on placebo. Beta cell function didn’t improve in either group.
- **A placenta MSC pilot (2011).** Ten people with long-standing, insulin-treated type 2 diabetes received three IV infusions of placenta-derived MSCs. Average insulin doses dropped and C-peptide rose over at least three months. There was no comparison group, so we can’t tell how much of that came from the cells.
- **Pooled analysis (2024).** A meta-analysis of 13 randomized trials (507 patients with type 1 or type 2 diabetes) found that, at 12 months, A1C was about 0.7 points lower and daily insulin needs were lower in people who received MSCs than in control groups. Fasting glucose wasn’t significantly different, and results varied a lot between studies.

A few cautions matter. Most of these trials were small, done at single centers in China, and enrolled people already on insulin. They used repeated infusions dosed by body weight, and the benefit wore off within about two years in the one long study. MSC therapy is not approved by the U.S. FDA for diabetes, and major diabetes organizations don’t recommend it outside research.

## What Stem Cell Therapy Can and Can't Do

Based on that evidence, here’s how we’d put it:

- It **isn’t a cure** and doesn’t rebuild a damaged pancreas.
- In trials, **some** people had a modest drop in A1C and needed less insulin. Many did not reach their goals, and effects faded over time.
- It **hasn’t been shown** to replace diabetes medicines, and stopping them on your own can be dangerous.
- It’s offered as an **addition to** your regular diabetes care, alongside nutrition, activity and the medicines your doctor prescribes.

## Our Type 2 Diabetes Protocol

Our protocol is published on our [type 2 diabetes treatment page](https://dreambody.clinic/type-2-diabetes-stem-cell-treatment/):

- Bloodwork and physician review before treatment
- A 300 million MSC IV infusion
- An NAD+ and high-dose vitamin C IV drip after the stem cells

**Price:** $11,500 USD, all-inclusive of the bloodwork, cells, IV drip and physician review.

The cells are allogeneic MSCs, meaning they come from donated Wharton’s jelly (umbilical cord tissue) and placenta after healthy births. They’re expanded in our on-site lab, which holds three COFEPRIS licenses, and tested by authorized third-party labs. Cells come out of culture the day before treatment and are given within 24 hours. You can read more on our [certified stem cells page](https://dreambody.clinic/certified-stem-cells/).

Note that this protocol rests on our physicians’ experience and the broader MSC research above. The published trials gave two or three smaller infusions spaced a month apart. No published trial has tested a single 300 million cell infusion with this IV drip for type 2 diabetes.

## Risks and Side Effects

In studies, IV MSCs have generally been well tolerated, and long-term data are still limited. On our treatment page, the most common reaction we report is a mild fever or headache for a few hours afterward or the next day, in about 1 in 100 people. Any IV carries a small risk of infection and, rarely, of a clot. That’s one reason everyone has bloodwork first.

For people with diabetes, there’s one more thing to plan for: **low blood sugar**. If your body starts using insulin better while your doses stay the same, your glucose could drop too low, especially if you take insulin or a sulfonylurea. Check your glucose more often in the weeks after treatment, know the signs of a low (shakiness, sweating, confusion) and how to treat one, and work with your own doctor on any dose changes. Travel itself, with new food and a different schedule, can also move your numbers.

## Who May Be a Candidate?

A physician decides after reviewing your records, and treatment is given only after your bloodwork clears. In general, a person who may be a reasonable candidate:

- Has a confirmed type 2 diabetes diagnosis with recent labs, ideally including A1C and C-peptide
- Has reasonably stable blood sugar, without recent episodes of severe lows or very high readings
- Has a primary care doctor or endocrinologist who will manage medicines before and after the trip
- Is fit to travel and to spend a few days away from home
- Understands this is investigational and plans to stay on regular care

We don’t treat anyone who has had cancer in the past five years. We may also advise against treatment for people with advanced kidney disease, uncontrolled heart disease, an active foot ulcer or infection, or poorly controlled blood sugar. This article covers type 2 diabetes only. Type 1 diabetes is a different disease, and the evidence here doesn’t apply to it.

## Your Trip

We ask you to be in town for at least four days. A typical schedule looks like this (exact days can shift with availability, and longer stays may not be consecutive days):

- **Day 1:** Arrive and rest
- **Day 2:** Bloodwork, physician review and payment if you’re cleared
- **Day 3:** Stem cell IV followed by the NAD+ and vitamin C drip
- **Day 4:** Fly home

Bring your glucose meter or sensor, extra supplies, and your medicines in your carry-on, plus a medication list and your recent labs. Insulin should stay out of checked bags. Pack snacks for flights in case of a low. Our coordinators can help with hotels and transport; see our [hotels page](https://dreambody.clinic/hotels/) and [travel guide](https://dreambody.clinic/travel-guide-stem-cell-treatment-bucerias/).

## After Treatment

Any change is likely to be gradual and varies from person to person. Before you travel, record a baseline with your own doctor: A1C, fasting glucose, your current doses and, if possible, C-peptide. Repeat A1C about three months after treatment, since that’s how long it takes to reflect a change. We follow up remotely at 3, 6 and 12 months. In the longest published trial, the benefit lasted about 21 months before fading, so keep up the habits and medical care that protect your heart, kidneys, eyes and feet.

## Questions to Ask Any Clinic

Whether you choose us or someone else, ask:

1. What cells are you using, where are they made, and what testing do they pass?
2. What do the randomized trials show for type 2 diabetes, including how long results lasted?
3. How does your dose compare with the doses used in those trials?
4. How will you help me avoid low blood sugar after treatment?
5. What exactly is included in the price, and what happens if my bloodwork rules me out?
6. How will you follow up, and how will we measure whether it helped?

Our [guide to choosing a stem cell clinic](https://dreambody.clinic/how-to-choose-a-stem-cell-clinic/) covers these in more detail.

## Frequently Asked Questions

**Can stem cells cure type 2 diabetes?** No. In randomized trials, MSCs led to modest improvements in A1C and insulin needs for some people, and those effects faded over about two years in the longest study. They don’t rebuild the pancreas.

**Will I be able to stop insulin or my diabetes pills?** Don’t count on it, and never stop or lower a medicine on your own. In the largest placebo-controlled trial, 1 in 5 treated patients reached the study’s goal of good control with half the insulin. Any change should be made by your own doctor based on your glucose readings.

**How soon would I notice a difference?** If there’s a change, it usually shows up gradually. A1C reflects about three months of blood sugar, so that’s the earliest point for a meaningful comparison.

**Can stem cells help diabetic nerve pain?** That’s a separate question with its own evidence. See our [guide to stem cell therapy for peripheral neuropathy](https://dreambody.clinic/stem-cell-therapy-peripheral-neuropathy/).

**Will insurance cover it?** Insurance generally doesn’t cover stem cell therapy for diabetes, and many U.S. insurers classify it as experimental.

## Thinking About Your Options?

If you’re wondering whether MSC therapy is worth exploring alongside your current care, a free consultation is a good place to start. It’s a conversation, not a commitment. A physician will review your labs and medicines, explain what the trials do and don’t show, and tell you honestly whether this protocol makes sense for you.

**[Schedule your free consultation](https://dreambody.clinic/contact/)**, call (888) 704-3977, WhatsApp +52 322 232 1055, or email info@dreambodyclinic.net.

---

*Disclaimer: This article is for educational purposes and is not medical advice. Mesenchymal stem cell therapy for type 2 diabetes is investigational and is not approved by the U.S. FDA. Published human evidence is limited, results vary, effects in trials faded over time, and some patients see little or no benefit. Treatment is provided in Mexico at a COFEPRIS-licensed facility. Do not stop or change any diabetes medication or insulin dose without your own doctor. Please consult your physician before making treatment decisions.*
